Strategies for a two-step liver fibrosis assessment in clinical practice.
作者信息
Vieira Barbosa Joana, Lai Michelle
机构信息
Division of Gastroenterology and Hepatology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, United States.
Division of Gastroenterology and Hepatology, University Hospital of Lausanne and University of Lausanne, Switzerland.
出版信息
JHEP Rep. 2021 Oct 5;4(1):100382. doi: 10.1016/j.jhepr.2021.100382. eCollection 2022 Jan.
Abstract
摘要
相似文献
1
Strategies for a two-step liver fibrosis assessment in clinical practice.临床实践中两步法肝纤维化评估策略。
JHEP Rep. 2021 Oct 5;4(1):100382. doi: 10.1016/j.jhepr.2021.100382. eCollection 2022 Jan.
2
Distribution of liver stiffness in non-alcoholic fatty liver disease with higher fibrosis-4 index than low cut-off index.肝纤维化 4 指数高于低截断指数的非酒精性脂肪性肝病患者的肝硬度分布。
J Gastroenterol Hepatol. 2019 Aug;34(8):1411-1416. doi: 10.1111/jgh.14559. Epub 2019 Jan 6.
3
Histopathological differences utilizing the nonalcoholic fatty liver disease activity score criteria in diabetic (type 2 diabetes mellitus) and non-diabetic patients with nonalcoholic fatty liver disease.利用非酒精性脂肪性肝病活动评分标准对糖尿病（2型糖尿病）和非糖尿病非酒精性脂肪性肝病患者进行组织病理学差异分析。
World J Hepatol. 2015 Nov 8;7(25):2610-8. doi: 10.4254/wjh.v7.i25.2610.
4
Prognostic accuracy of FIB-4, NAFLD fibrosis score and APRI for NAFLD-related events: A systematic review.FIB-4、非酒精性脂肪性肝病纤维化评分和APRI对非酒精性脂肪性肝病相关事件的预后准确性：一项系统评价。
Liver Int. 2021 Feb;41(2):261-270. doi: 10.1111/liv.14669.
5
Trend over time in hepatic fibrosis score in a cohort of type 2 diabetes patients.2 型糖尿病患者队列中肝纤维化评分的时间趋势。
Diabetes Res Clin Pract. 2018 Jan;135:65-72. doi: 10.1016/j.diabres.2017.10.023. Epub 2017 Oct 31.
6
Diagnostic performance of three non-invasive fibrosis scores (Hepamet, FIB-4, NAFLD fibrosis score) in NAFLD patients from a mixed Latin American population.三种非侵入性纤维化评分（Hepamet、FIB-4、NAFLD 纤维化评分）在混合拉丁美洲人群中 NAFLD 患者中的诊断性能。
Ann Hepatol. 2020 Nov-Dec;19(6):622-626. doi: 10.1016/j.aohep.2020.08.066. Epub 2020 Sep 9.
7
Utility of Multiparametric CT for Identification of High-Risk NAFLD.多参数 CT 在识别高危非酒精性脂肪性肝病中的应用。
AJR Am J Roentgenol. 2021 Mar;216(3):659-668. doi: 10.2214/AJR.20.22842. Epub 2021 Jan 21.
8
Identifying Nonalcoholic Fatty Liver Disease Advanced Fibrosis in the Veterans Health Administration.在退伍军人健康管理局中识别非酒精性脂肪性肝病的肝纤维化程度。
Dig Dis Sci. 2018 Sep;63(9):2259-2266. doi: 10.1007/s10620-018-5123-3. Epub 2018 May 19.
9
IMPACT OF TYPE 2 DIABETES ON NONALCOHOLIC STEATOHEPATITIS AND ADVANCED FIBROSIS IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE.2 型糖尿病对非酒精性脂肪性肝病患者非酒精性脂肪性肝炎和肝纤维化进展的影响。
Endocr Pract. 2020 Apr;26(4):444-453. doi: 10.4158/EP-2019-0342. Epub 2020 Jan 22.
10
Association between noninvasive assessment of liver fibrosis and coronary artery calcification progression in patients with nonalcoholic fatty liver disease.非酒精性脂肪性肝病患者肝纤维化无创评估与冠状动脉钙化进展的相关性。
Sci Rep. 2020 Oct 27;10(1):18323. doi: 10.1038/s41598-020-75266-4.
引用本文的文献
1
Diagnosis and Management of Lean Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A Systematic Review.瘦素代谢功能障碍相关脂肪性肝病（MASLD）的诊断与管理：一项系统评价
Cureus. 2024 Oct 14;16(10):e71451. doi: 10.7759/cureus.71451. eCollection 2024 Oct.
本文引用的文献
1
Embedding assessment of liver fibrosis into routine diabetic review in primary care.将肝纤维化评估纳入基层医疗中糖尿病常规复诊流程。
JHEP Rep. 2021 Apr 22;3(4):100293. doi: 10.1016/j.jhepr.2021.100293. eCollection 2021 Aug.
2
Nonalcoholic Fatty Liver Disease Screening in Type 2 Diabetes Mellitus Patients in the Primary Care Setting.非酒精性脂肪性肝病筛查在基层医疗环境中的 2 型糖尿病患者。
Hepatol Commun. 2020 Oct 31;5(2):158-167. doi: 10.1002/hep4.1618. eCollection 2021 Feb.
3
4. Comprehensive Medical Evaluation and Assessment of Comorbidities: .4. 全面的医学评估和共病评估：。
Diabetes Care. 2020 Jan;43(Suppl 1):S37-S47. doi: 10.2337/dc20-S004.
4
Referral pathways for NAFLD fibrosis in primary care - No longer a 'needle in a haystack'.
J Hepatol. 2019 Aug;71(2):246-248. doi: 10.1016/j.jhep.2019.05.010. Epub 2019 Jun 20.
5
Impact of an electronic medical record reminder on hepatitis B vaccine initiation and completion rates among insured adults with diabetes mellitus.电子病历提醒对有保险的糖尿病成年人乙型肝炎疫苗接种启动和完成率的影响。
Vaccine. 2019 Jan 3;37(1):195-201. doi: 10.1016/j.vaccine.2018.06.035. Epub 2018 Jun 27.
6
Patient navigators for people with chronic disease: A systematic review.慢性病患者的患者导航员：一项系统综述。
PLoS One. 2018 Feb 20;13(2):e0191980. doi: 10.1371/journal.pone.0191980. eCollection 2018.
7
Patient navigation to improve diabetes outpatient care at a safety-net hospital: a retrospective cohort study.患者导航改善安全网医院糖尿病门诊护理：一项回顾性队列研究。
BMC Health Serv Res. 2017 Nov 21;17(1):759. doi: 10.1186/s12913-017-2700-7.
8
EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease.欧洲肝脏研究学会-欧洲糖尿病研究学会-欧洲肥胖症研究学会非酒精性脂肪性肝病管理临床实践指南
J Hepatol. 2016 Jun;64(6):1388-402. doi: 10.1016/j.jhep.2015.11.004. Epub 2016 Apr 7.
9
Estimating a reasonable patient panel size for primary care physicians with team-based task delegation.基于团队任务分工估算基层医疗医师的合理患者人数。
Ann Fam Med. 2012 Sep-Oct;10(5):396-400. doi: 10.1370/afm.1400.
10
Time allocation in primary care office visits.基层医疗门诊就诊的时间分配
Health Serv Res. 2007 Oct;42(5):1871-94. doi: 10.1111/j.1475-6773.2006.00689.x.
Zotero 插件